Project Grant R01HL179086
Award Date 9/1/25
Completion Date 6/30/29
Dollars Obligated $784K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60611, USA
Similar Awards
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $760,083 Project Grant to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, under the Cardiovascular Diseases Research program (CFDA 93.837). The grant aims to investigate the role of the protein C system in trauma-induced coagulopathy and thromboinflammation, with the goal of developing targeted therapies. The project will examine the mechanisms underlying the protein C system's dual...
- This Project Grant award, valued at $748,965.00, was provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Northwestern University for a research project titled "Vascular Proliferative Resilience - Summary in Adults". The project aims to investigate the dynamics, spatial context, and molecular regulators of endothelial cell proliferation in the aorta, with the goal of deciphering the mechanisms underlying the maintenance of vascular...
- This federal Project Grant award, valued at $272,226.00, was granted by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837). The project aims to determine how clinician and scheduling characteristics impact patient outcomes, and explore the moderating effect of patient characteristics on these relationships, for mechanically ventilated adults in intensive care units. The project will conduct a novel secondary analysis utilizing a unique...
- This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $1,087,534.00 to the University of Washington to develop novel, synthetic therapies for stabilizing trauma victims in the critical "golden hour" after injury. The key objectives are to: 1) develop low-volume resuscitants that provide fluid...
- This $1,380,474 federal Project Grant awarded on September 24, 2025 by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to improve the care of patients with acute heart and lung diseases. The University of Michigan will develop data-driven models to support improved decision-making for intensive care unit (ICU) triage and inpatient bed assignment. The project will identify determinants of triage and bed assignment, develop a clinical decision...
- The Project Grant award titled "FUNCTIONAL COAGULATION AND HEMOSTASIS AFTER INTRACEREBRAL HEMORRHAGE (FIGHT-ICH)" is being provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to The Trustees of Columbia University in the City of New York for $829,103.00. The award commences on July 20, 2025 and is set to conclude on April 30, 2030. The grant supports research focused on understanding coagulation and hemostasis processes in patients...
- This $405,000 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), will support a research project titled "Hemorrhage and Hemorrheology - The Critical Interaction of the Erythrocyte and the Endothelium After Injury." The project aims to better understand the relationship between red blood cells and the endothelium (inner lining of blood vessels) following traumatic injury,...
- This federal Project Grant award of $110,635.00 from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to characterize how red blood cell aggregation and membrane deformability affect endothelial cell injury and microvascular thrombosis in sepsis patients. The project will use microfluidics assays to analyze patient blood samples and apply machine learning to determine the impact of rheology on clinical outcomes. The research will also assess the...
- This Project Grant award of $234,000.00 was provided by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to the University of Colorado-Denver to develop "hemostatic red blood cells" (T-RBCs) that can bind to collagen and fibrin to enhance clot formation and stability. The goal is to create a novel technology to address severe, non-compressible bleeding, which is a major cause of mortality worldwide, especially in low-resource settings. The...
- This $2,394,542 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will fund a randomized controlled trial to test the effect of transferring patients resuscitated from out-of-hospital cardiac arrest to a specialty cardiac care center versus usual care. The study aims to: 1) estimate the impact of specialty cardiac care on functional recovery, 2) identify the minimum clinical and operational standards for specialty cardiac arrest...